High Rates Of Scanning With Abbott′s FreeStyle Libre System Linked To Improved Glucose Control In Diabetes Patients

High rates of scanning with Abbott′s FreeStyle Libre system linked to improved glucose control in diabetes patients

High rates of scanning with Abbott′s FreeStyle Libre system linked to improved glucose control in diabetes patients

Abbott today announced the results of real-world use data showing that people who scan more frequently using Abbott′s FreeStyle® Libre system spend less time in hypoglycaemia (low blood sugar) or hyperglycaemia (high blood sugar) while having improved average glucose levels. According to the data, more than 50,000 people with diabetes using the FreeStyle Libre system checked their glucose levels an average of 16 times per day—which is three times more than the minimum recommended U.S. and European guidelines for testing with the traditional fingerstick technique. The data show that higher rates of scanning with the FreeStyle Libre system were found to be strongly associated with improved glucose control.
"There is now substantial evidence from both real-world usage and clinical studies that reaffirms the powerful impact of the FreeStyle Libre system," said Jared Watkin, senior vice president, Diabetes Care, Abbott. "The FreeStyle Libre system is changing how diabetes has been managed for decades, with one simple swipe. Most importantly, we’re doing that by empowering patients with the information that they need to take action themselves, helping people living with diabetes live fuller, healthier lives."
Abbott′s FreeStyle Libre system consists of a small, round sensor worn on the back of the upper arm for up to 14 days, which measures glucose every minute in interstitial fluid through a small filament that is inserted just under the skin and held in place with a small adhesive pad.
The FreeStyle Libre reader is scanned over the sensor to get a glucose result in les Continue reading

Rate this article
Total 1 ratings
Continuous glucose monitoring for pregnant women with type 1 diabetes reduces risk of complications for newborns

Continuous glucose monitoring for pregnant women with type 1 diabetes reduces risk of complications for newborns

Continuous glucose monitoring for pregnant women with type 1 diabetes reduces risk of complications for newborns
Authors say that continuous glucose monitoring should be offered to all pregnant women with type 1 diabetes to reduce risk of complications for newborn babies
For women with type 1 diabetes, monitoring blood sugar levels continuously during pregnancy via an implanted device helps better manage the disease, and improves birth outcomes compared to traditional finger-prick tests, according to a new randomized trial published in The Lancet and presented at the European Association for the Study of Diabetes (EASD) conference.
One in two newborns of women with type 1 diabetes may face complications as a result of being exposed to maternal high blood sugar levels, and there has been limited progress, with these birth outcomes not improving in the past 3-4 decades.
Complications can include congenital anomaly, premature birth, stillbirth, need for intensive care after birth, and being larger than average at birth for the baby, and higher rates of pre-eclampsia and Caesarean section for the mother.
The authors of the international trial say that, as a result of these findings, this type of monitoring should now be offered to all pregnant women with type 1 diabetes to help improve outcomes for newborns.
In the study, researchers trialled an implanted continuous glucose monitoring (CGM) device that gives 288 glucose recordings per day, allowing users to recognise and respond to changes in blood sugar levels as they occur. They compared this with traditional monitori Continue reading

Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes  United States and Puerto Rico, 20002014

Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes United States and Puerto Rico, 20002014

Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons with Diagnosed Diabetes United States and Puerto Rico, 20002014
Weekly / November 3, 2017 / 66(43);11651170
The incidence of end-stage renal disease attributed to diabetes (ESRD-D) in the U.S. population with diagnosed diabetes began to decline in the mid-1990s.
During 20002014, the age-standardized incidence of ESRD-D has continued to decline significantly in the United States and in most states, the District of Columbia, and Puerto Rico. No state experienced an increase in rates.
What are the implications for public health practice?
Continued awareness of diabetes and interventions to reduce the prevalence of risk factors for kidney failure, improve diabetes care, and prevent type 2 diabetes might sustain the decline in ESRD-D incidence rates in the population with diagnosed diabetes.
During 2014, 120,000 persons in the United States and Puerto Rico began treatment for end-stage renal disease (ESRD) (i.e., kidney failure requiring dialysis or transplantation) (1). Among these persons, 44% (approximately 53,000 persons) had diabetes listed as the primary cause of ESRD (ESRD-D) (1). Although the number of persons initiating ESRD-D treatment each year has increased since 1980 (1,2), the ESRD-D incidence rate among persons with diagnosed diabetes has declined since the mid-1990s (2,3). To determine whether ESRD-D incidence has continued to decline in the United States overall and in each state, the District of Columbia (DC), and Puerto Rico, CDC analyzed 20002014 data from the U.S. Renal Data S Continue reading

Children and Type 2 Diabetes: Whats New?

Children and Type 2 Diabetes: Whats New?

Children and Type 2 Diabetes: Whats New?
No one likes hearing that they cant have something, especially the foods they love. Children with Type 2 diabetes have an especially complicated relationship with food. Type 2 diabetes is becoming more common; more than 80% of all children and teens with Type 2 diabetes are overweight, and about 40% are clinically obese. Because weight is a contributing factor to Type 2 diabetes, it is important to look for new ways to help children control their weight and to understand which new medical treatments are available. While children have little control over the foods in their environment, some new practices can help them choose healthier foods and eat mindfully. Some new devices and medicines also may potentially help control children and teens glucose levels. It is important to remember that it will most likely be a combination of interventions that will help your child learn to live with the disease and become healthier over time.
One practice that is gaining popularity is called mindful eating or eating with intention. A recent study has showed that when parents restrict food to promote healthier behaviors, it will work in the short-term. However, in the long-term, restrictive eating has proved to be harmful. Children who have restricted diets are at risk for increased eating when they are not hungry, not learning how to self-regulate and trust their bodys signals, thus causing weight gain. The approach to mindful eating is to help the child create a dialog of kindness with his or her own body. Instead of focusing on hunger as a n Continue reading

All About Needles Used for Diabetes | Ask D'Mine

All About Needles Used for Diabetes | Ask D'Mine

Written by Wil Dubois on September 16, 2017
Hey, All -- Got questions about life with diabetes? Then you've come to the right place! That would be our weekly diabetes advice column, Ask D'Mine, hosted by longtime type 1 and diabetes author W il Dubois in New Mexico, who spent many years working as a clinical specialist helping those with diabetes.
This week, he takes on a trio of questions about needles and injection-related therapy. Here's Wil, "taking a stab" at this theme...
{Got your own questions? Email us at [email protected] }
Natsu, type 1 from Japan, asks: Is it possible to hit an organ when inserting a diabetic cannula on the stomach?
[email protected] DMine answers: Nope! Your innards are fully safe and secure. OK, in point of fact, most cannulas are worn on the stomach, so your worry is common. In fact, before my own diagnosis one of my wifes aunts had type 2 requiring insulin, and I knew she took shots in the stomach. I ignorantly assumed she used some giant six-inch needle and had to insert this medieval torture device all the way into her stomach. Every day.
Under the circumstances, I found her to be a remarkably jolly person.
Later, when my own doctor calmly told me that I needed to take shots in my stomach, I nearly fainted. Of course, the truth is we take our shots into the insulating fat layer below the skin -- a layer of fat that even skinny people have, and is thicker than youd think. Oh, and below that fat is a layer of muscle. The organs are below the muscle. So you can see youve got quite a bit of issue between the top of the skin an your inte Continue reading

No more pages to load

Popular Articles

  • Understudied racial minority groups show alarmingly high rates of obesity and diabetes

    RIVERSIDE, Calif. – Some of the smallest and historically neglected racial groups in the United States experience far more obesity, diabetes, and other health conditions than non-Hispanic white adults, a study by researchers at the University of California, Riverside has found. Using data for nearly 185,000 adults from the California Health Interview Survey (CHIS), the study reports that multira ...

  • FDA Approves MiniMed 670G System – World’s First Hybrid Closed Loop System

    the first hybrid closed loop system in the world! This approval is a significant milestone in the history of diabetes management, and a culmination of many years of dedicated work. With this approval, we are one step closer to delivering a fully automated closed loop system. You may be wondering how this system is different from the MiniMed 630G system we recently launched in the U.S. Advanced Sma ...

  • Team-based approach helps patients better control type 2 diabetes

    Nearly one in four patients who walks through the door of a suburban Chicago community-based health clinic has type 2 diabetes and the clinic’s team-based approach in managing the condition—from pre-visit laboratory testing to the daily huddle—has gone a long way in effectively managing these complex patients, including helping to control A1C levels. An AMA STEPS Forward™ module explains h ...

  • The 30-minute op that can save diabetes patients from losing a leg - so why aren't more patients being offered this?

    Last year, Graham Baker was facing the prospect of losing his left leg below the knee, a complication of his type 2 diabetes. Poorly controlled blood sugar levels had encouraged the arteries in his left calf to fur up, and this was obstructing the blood flow so much that the tissues and bones in his lower leg were being starved of blood and oxygen. ‘I had a scan to monitor the blood flow in my l ...

  • Periodontal Disease Linked with Diabetes and Heart Health

    Forty-seven percent of adults age 30 years and older have some form of periodontal disease, according to the Centers for Disease Control. In individuals 65 years and older, the number jumps to a staggering 70.1 percent. Periodontal disease creates a heightened systemic response linked with heart disease, diabetes, obesity, and several other disorders. Nutrient deficiencies like magnesium and coenz ...

  • Drinking Wine Is Linked to a Lower Risk of Diabetes

    TIME Health For more, visit TIME Health. Drinking alcohol—especially wine—every few days may help protect against type 2 diabetes, suggests a new study published in the journal Diabetologia. People in the study who drank three to four days a week were about 30% less likely to develop diabetes than those who drank less than once a week. This isn’t the first study to find a link between drinki ...

  • Cholesterol-Lowering Drugs May Be Linked to Diabetes

    You may have concerns about taking a cholesterol-lowering statin drug, such as atorvastatin (Lipitor and generic), rosuvastatin (Crestor), and simvastatin (Zocor and generic), after a recent study linked those drugs to an increased risk of type 2 diabetes. But Consumer Reports Best Buy Drugs experts say the heart-protective benefit of statins usually outweighs the risk of diabetes, so don’t skip ...

  • Diabetes and obesity linked to number of nearby fast-food outlets, study finds

    Diabetes and obesity rates in inner cities can be linked to the number of fast-food outlets near people’s homes, a study has found. Scientists based their conclusion on a study of 10,000 people in the UK. They found there were twice as many fast-food outlets within 500 metres of homes in non-white and socially deprived neighbourhoods. The lead researcher, Prof Kamlesh Khunti from the University ...

  • Drinking moderately linked to lower diabetes risk

    Drinking three to four times a week has been linked to a lower risk of type 2 diabetes than never drinking, Danish researchers suggest. Wine appears to be particularly beneficial, probably as it plays a role in helping to manage blood sugar, the study, published in Diabetologia, says. They surveyed more than 70,000 people on their alcohol intake - how much and how often they drank. But experts sai ...

Related Articles